Cargando…

Withaferin A Acts as a Novel Regulator of Liver X Receptor-α in HCC

Withaferin A, a steroidal lactone derived from the Withania somnifera plant has been known for its anti-cancerous effects on various types of cancer cells. However, its effect on the hallmarks of cancer such as proliferation, migration, invasion, and angiogenesis is still poorly understood. The anti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shiragannavar, Varsha D., Gowda, Nirmala G. Sannappa, Kumar, Divya P., Mirshahi, Faridoddin, Santhekadur, Prasanna K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878559/ https://www.ncbi.nlm.nih.gov/pubmed/33585254 http://dx.doi.org/10.3389/fonc.2020.628506

Ejemplares similares

The ameliorating effect of withaferin A on high-fat diet-induced non-alcoholic fatty liver disease by acting as an LXR/FXR dual receptor activator
por: Shiragannavar, Varsha D., et al.
Publicado: (2023)

Is circulating exosome carry Staphylococcal nuclease domain-containing protein 1, a component of RNA-induced silencing complex?
por: Shiragannavar, Varsha D., et al.
Publicado: (2020)

Novel Insights into MEG3/miR664a-3p/ADH4 Axis and Its Possible Role in Hepatocellular Carcinoma from an in Silico Perspective
por: Karunakara, Shreyas H., et al.
Publicado: (2022)

Quercetin activates vitamin D receptor and ameliorates breast cancer induced hepatic inflammation and fibrosis
por: Sannappa Gowda, Nirmala G., et al.
Publicado: (2023)

Editorial: Chemotherapy in esophageal cancer
por: Chen, Jiang, et al.
Publicado: (2022)

Editorial: Recent advances in the understanding of hepatocellular carcinogenesis
por: Banini, Bubu A., et al.
Publicado: (2022)

The Transcriptomic Signature Of Disease Development And Progression Of Nonalcoholic Fatty Liver Disease
por: Cazanave, Sophie, et al.
Publicado: (2017)

Author Correction: The Transcriptomic Signature Of Disease Development And Progression Of Nonalcoholic Fatty Liver Disease
por: Cazanave, Sophie, et al.
Publicado: (2020)

AATF inhibition exerts antiangiogenic effects against human hepatocellular carcinoma
por: Suresh, Diwakar, et al.
Publicado: (2023)

Potential candidates for liver resection in liver-confined advanced HCC: a Chinese multicenter observational study
por: Bai, Tingting, et al.
Publicado: (2023)

Outcomes of Liver Resection for Metabolic Dysfunction-Associated Fatty Liver Disease or Chronic Hepatitis B-Related HCC
por: Liu, Lei, et al.
Publicado: (2022)

RISC assembly and post-transcriptional gene regulation in Hepatocellular Carcinoma
por: Santhekadur, Prasanna K., et al.
Publicado: (2019)

Splenic Volume, an Easy-To-Use Predictor of HCC Late Recurrence for HCC Patients After Hepatectomy
por: Fang, Tongdi, et al.
Publicado: (2022)

Restoration of CD4(+) T Cells during NAFLD without Modulation of the Hepatic Immunological Pattern Is Not Sufficient to Prevent HCC
por: Isbell, Madison, et al.
Publicado: (2022)

Immune Checkpoint Inhibitors in the Treatment of HCC
por: Donisi, Clelia, et al.
Publicado: (2021)

HDR Brachytherapy and SBRT as Bridging Therapy to Liver Transplantation in HCC Patients: A Single-Center Experience
por: Walter, Franziska, et al.
Publicado: (2021)

Herbal Immunity Booster-Associated Liver Injury During COVID-19 Pandemic and Aflatoxins
por: Vamadevaiah, Ravishankar M., et al.
Publicado: (2022)

Study on the changes of CT texture parameters before and after HCC treatment in the efficacy evaluation and survival predication of patients with HCC
por: Zhou, Wei, et al.
Publicado: (2022)

Can Risk Stratification Based on Ultrasound Elastography of Background Liver Assist CEUS LI-RADS in the Diagnosis of HCC?
por: Li, Jiawu, et al.
Publicado: (2021)

A novel HCC prognosis predictor PDSS1 affects the cell cycle through the STAT3 signaling pathway in HCC
por: Rao, Zuqin, et al.
Publicado: (2022)

Implications of Withaferin A in neurological disorders
por: Ram, Natasha, et al.
Publicado: (2020)

The Combination of AFP and “Up-To-Seven” Criteria May Be a Better Strategy for Liver Transplantation in Chinese Cirrhotic HCC Patients
por: Zhang, Da-li, et al.
Publicado: (2022)

Agonists Specific for κ-Opioid Receptor Induces Apoptosis of HCC Cells Through Enhanced Endoplasmic Reticulum Stress
por: Tan, Mengyuan, et al.
Publicado: (2022)

Bacteria-Mediated Oncogenesis and the Underlying Molecular Intricacies: What We Know So Far
por: Prasad, Shashanka K., et al.
Publicado: (2022)

Upregulation of Serum Sphingosine (d18:1)-1-P Potentially Contributes to Distinguish HCC Including AFP-Negative HCC From Cirrhosis
por: Jiang, Yingying, et al.
Publicado: (2020)

NEDD4 Induces K48-Linked Degradative Ubiquitination of Hepatitis B Virus X Protein and Inhibits HBV-Associated HCC Progression
por: Wan, Tao, et al.
Publicado: (2021)

HCV Eradication with Direct-Acting Antivirals Does Not Impact HCC Progression on the Waiting List or HCC Recurrence after Liver Transplantation
por: Emamaullee, Juliet A., et al.
Publicado: (2019)

A Nomogram Based on Preoperative Inflammatory Indices and ICG-R15 for Prediction of Liver Failure After Hepatectomy in HCC Patients
por: Fang, Tongdi, et al.
Publicado: (2021)

A high preoperative serum IL-25 level is a negative prognosis predictor after liver resection for HBV-HCC
por: Chen, Shao-hua, et al.
Publicado: (2022)

Erratum: Agonists Specific for κ-Opioid Receptor Induces Apoptosis of HCC Cells Through Enhanced Endoplasmic Reticulum Stress
Publicado: (2022)

Kill and Clearance in HCC: An Approach Based on NK Cells and Macrophages
por: Mehrabi, Maryam, et al.
Publicado: (2021)

Cabozantinib for HCC Treatment, From Clinical Back to Experimental Models
por: Deng, Shanshan, et al.
Publicado: (2021)

Epigenetic Mechanisms Involved in HCV-Induced Hepatocellular Carcinoma (HCC)
por: Zhao, Pin, et al.
Publicado: (2021)

Evaluation of D-TACE combined with endovascular brachytherapy for HCC with MPVTT
por: Huang, Wei, et al.
Publicado: (2022)

Hsa-miR-4277 Decelerates the Metabolism or Clearance of Sorafenib in HCC Cells and Enhances the Sensitivity of HCC Cells to Sorafenib by Targeting cyp3a4
por: He, Xi, et al.
Publicado: (2021)

The dark face of fructose as a tumor promoter
por: Santhekadur, Prasanna K.
Publicado: (2019)

Roles of lncRNAs Mediating Wnt/β-Catenin Signaling in HCC
por: Xu, Yating, et al.
Publicado: (2022)

Targeting mitochondrial quality control of T cells: Regulating the immune response in HCC
por: Xia, Yixue, et al.
Publicado: (2022)

A key driver to promote HCC: Cellular crosstalk in tumor microenvironment
por: Liu, Pengyue, et al.
Publicado: (2023)

A New Prognostic Algorithm Predicting HCC Recurrence in Patients With Barcelona Clinic Liver Cancer Stage B Who Received PA-TACE
por: Hu, Shuyang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a1tgabdtvsqa1iv4i2a2q07qaq